Date published: 2026-3-3

1-800-457-3801

SCBT Portrait Logo
Seach Input

POLR2I Inhibitors

POLR2I, a subunit of the RNA polymerase II complex, plays a crucial role in the transcriptional machinery of eukaryotic cells, facilitating the transcription of DNA into messenger RNA. This process is central to gene expression and the subsequent protein synthesis essential for various cellular functions and physiological processes. The RNA polymerase II complex, composed of multiple subunits including POLR2I, is responsible for the transcription of protein-coding genes, making its activity fundamental to the regulation of gene expression. POLR2I, in particular, contributes to the structural and functional integrity of the complex, ensuring its proper assembly and facilitating the initiation of transcription. Given its pivotal role, the inhibition of POLR2I can significantly impact the transcriptional activity of RNA polymerase II, leading to alterations in gene expression patterns that may affect cellular homeostasis and function.

The inhibition of POLR2I, and consequently of RNA polymerase II activity, can be mediated through various mechanisms, reflecting the complex regulation of transcription. One primary mode of inhibition involves the alteration of the phosphorylation status of the RNA polymerase II complex, particularly the carboxy-terminal domain (CTD) of its largest subunit. Phosphorylation of the CTD is crucial for the transition from transcription initiation to elongation, and its dephosphorylation or inappropriate phosphorylation can stall the polymerase at the promoter, inhibiting transcriptional activity. Additionally, direct binding of inhibitory proteins or small molecules to POLR2I or other subunits of the polymerase complex can physically obstruct the transcription machinery, preventing the initiation or elongation of transcription. Regulatory pathways that modulate the expression or stability of POLR2I itself can also serve as a means of inhibition, impacting the assembly and functionality of the RNA polymerase II complex. Through these mechanisms, the activity of POLR2I can be finely controlled, allowing cells to respond to internal and external cues by modulating gene expression patterns, thereby maintaining cellular and physiological homeostasis.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

α-Amanitin

23109-05-9sc-202440
sc-202440A
1 mg
5 mg
$269.00
$1050.00
26
(2)

Direct inhibitor of RNA polymerase II, preventing mRNA synthesis.

DRB

53-85-0sc-200581
sc-200581A
sc-200581B
sc-200581C
10 mg
50 mg
100 mg
250 mg
$43.00
$189.00
$316.00
$663.00
6
(1)

Inhibits RNA polymerase II phosphorylation, thereby inhibiting its activity.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

Intercalates DNA, preventing RNA polymerase movement and transcription.

Ibrutinib

936563-96-1sc-483194
10 mg
$156.00
5
(0)

BTK inhibitor which can indirectly affect signaling pathways that modulate RNA polymerase II activity.

Triptolide

38748-32-2sc-200122
sc-200122A
1 mg
5 mg
$90.00
$204.00
13
(1)

Directly binds and inhibits the XPB subunit of RNA polymerase II.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$57.00
$100.00
$250.00
129
(3)

Kinase inhibitor affecting multiple pathways, can indirectly impact RNA polymerase II.

Flavopiridol

146426-40-6sc-202157
sc-202157A
5 mg
25 mg
$78.00
$259.00
41
(3)

Cyclin-dependent kinase inhibitor, impacts RNA polymerase II phosphorylation.

(±)-JQ1

1268524-69-1sc-472932
sc-472932A
5 mg
25 mg
$231.00
$863.00
1
(0)

BET bromodomain inhibitor, impacts transcriptional regulation.

Pladienolide B

445493-23-2sc-391691
sc-391691B
sc-391691A
sc-391691C
sc-391691D
sc-391691E
0.5 mg
10 mg
20 mg
50 mg
100 mg
5 mg
$299.00
$5699.00
$11099.00
$25500.00
$66300.00
$2875.00
63
(2)

Binds to the SF3b complex affecting pre-mRNA splicing and indirectly affecting RNA polymerase II transcription.

THZ1

1604810-83-4sc-507542
1 mg
$95.00
(0)

Covalent CDK7 inhibitor, affects phosphorylation of RNA polymerase II C-terminal domain.